COMPANY
Clinical Phase 1
Keywords: antibody antibody-drug conjugate ADC oncology metastatic castration-resistant prostate cancer multiple myeloma Prostate Cancer Metastatic Multiple Myeloma in Relapse Multiple Myeloma With Failed Remission FOR46
Location: La Jolla, CA · source · Oct 13, 2026
Profile checked Oct 10, 2026
Timeline
- Trial start Phase 1: A Study of FOR46 in Patients With Relapsed or Refractory Multiple Myeloma (RRMM) source ↗
- Trial start 1: A Phase 1 Study of FOR46 in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) source ↗
Clinical trials (lead sponsor) 2
| Record | Title | Phase | Status | Start | Primary completion |
|---|
| NCT03575819 | A Phase 1 Study of FOR46 in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) | 1 | Completed | Feb 4, 2019 | Nov 16, 2023 (actual) |
| NCT03650491 | A Study of FOR46 in Patients With Relapsed or Refractory Multiple Myeloma (RRMM) | Phase 1 | Completed | Apr 3, 2019 | Jan 31, 2022 (actual) |
